In the ever-evolving life sciences industry, compliance is top-of-mind for investors, business leaders, the public and the government. Life sciences companies are subject to increased enforcement efforts and greater public scrutiny, and boards, investors, and other key stakeholders call for more and better compliance controls. As a result, there are increased expectations on what compliance programs should cover and what resources should be dedicated to making these programs successful.
With the growing importance of compliance for emerging life sciences companies, Goodwin and the Berkeley Research Group are pleased to announce our inaugural Foundations in Healthcare Compliance series, a multi-part training series where participants will learn from experienced lawyers and professionals about the various considerations when building and growing a compliance program in the life sciences industry.
This five-week series is designed for new compliance officers, in-house counsel or their delegates and investor clients seeking more information about compliance in the life sciences market. We will offer CLE credit for lawyer attendees and non-lawyer compliance certification (HCCA), if available.
For further information and to request an invitation to the series check out the Foundations in Healthcare Compliance mini site.
The post Goodwin Virtual Series: Foundations in Healthcare Compliance for Life Sciences Companies appeared first on Life Sciences Perspectives.